Source: Brazilian journal of medical and biological research. Unidade: FM
Subjects: HEPATITE B (TERAPIA;AVALIAÇÃO;VIROLOGIA), BIOQUÍMICA, RESISTÊNCIA MICROBIANA ÀS DROGAS, CONDUTAS TERAPÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANÇA, P. H. C. et al. The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation. Brazilian journal of medical and biological research, v. 40, n. 12, p. 1605-1614, 2007Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2006005000169. Acesso em: 23 maio 2024.APA
França, P. H. C., Coelho, H. S. M., Brandão, C. E., Segadas, J. A., Quintaes, R. F., Carrilho, F. J., et al. (2007). The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation. Brazilian journal of medical and biological research, 40( 12), 1605-1614. doi:10.1590/s0100-879x2006005000169NLM
França PHC, Coelho HSM, Brandão CE, Segadas JA, Quintaes RF, Carrilho FJ, Ono-Nita S, Mattos AA, Tovo C, Gouvea VS, Sablon E, Vanderborght BOM. The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation [Internet]. Brazilian journal of medical and biological research. 2007 ; 40( 12): 1605-1614.[citado 2024 maio 23 ] Available from: https://doi.org/10.1590/s0100-879x2006005000169Vancouver
França PHC, Coelho HSM, Brandão CE, Segadas JA, Quintaes RF, Carrilho FJ, Ono-Nita S, Mattos AA, Tovo C, Gouvea VS, Sablon E, Vanderborght BOM. The emergence of YMDD mutants precedes biochemical flare by 19 weeks in lamivudine-treated chronic hepatitis B patients: an opportunity for therapy reevaluation [Internet]. Brazilian journal of medical and biological research. 2007 ; 40( 12): 1605-1614.[citado 2024 maio 23 ] Available from: https://doi.org/10.1590/s0100-879x2006005000169